University of Toronto-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of Toronto - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013636
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Toronto (UT) is an educational and research service provider that offers undergraduate and postgraduate courses in various fields. The university offers courses in various fields such as applied science and engineering, architecture, landscape, design, arts and science, continuing studies, school of dentistry education, forestry education. It provides services such as arts, science and business, music, physical education and health, law, medical radiation sciences, medicine, nursing, pharmacy, biochemistry, biology, cell and systems biology, chemical and physical sciences, among others. The university conducts research and development on the areas of psychology, biology, public health sciences, environment sciences and Alzheimer diseases. It partners with researchers, government and industries across Brazil and Italy for its research activities. UT is headquartered in Toronto, Ontario, Canada.

University of Toronto – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University of Toronto, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University of Toronto, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University of Toronto, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University of Toronto, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
University of Toronto, Medical Devices Deals, 2011 to YTD 2017 10
University of Toronto, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
University of Toronto, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Celgene Partners with Recombinant Antibody Network 13
Edge Therapeutics Enters into Research and Discovery Agreement with St. Michael’s Hospital 15
Blueline Bioscience Forms Joint Venture with University of Toronto and University Health Network 16
Life Technologies Enters Into Joint Venture Agreement With Structural Genomics Consortium 17
Sanofi-aventis Enters Into Research Agreement With Sunnybrook Health Sciences Center 18
Licensing Agreements 19
Advanced Proteome Therapeutics Enters into Option Agreement with Toronto Recombinant Antibody Centre 19
InDanio Biosciences Receives Intellectual Property Rights from University of Toronto 20
Kolltan Pharma Enters Into Licensing Agreement With University of Toronto For Anti-KIT Antibodies And Related IP 21
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University Of Toronto 22
Asset Transactions 23
NovaDigm Therapeutics Acquires Rights to Beta-Mannan Trisaccharide Conjugate from University of Alberta, Louisiana State University School of Medicine and University of Toronto 23
Regen BioPharma to Acquire Cancer Stem Cell Intellectual Property from University of Toronto 24
University of Toronto – Key Competitors 25
University of Toronto – Key Employees 26
University of Toronto – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Affiliate 27
Joint Venture 28
Recent Developments 29
Strategy And Business Planning 29
Oct 11, 2017: University of Toronto and Medicxi launch Janpix to Advance Dual Impact Cancer Therapies 29
Government and Public Interest 30
Nov 06, 2017: Scientists discover potential treatment to stop glaucoma in its tracks 30
Oct 13, 2017: Neurotechnological innovation and organ-on-a-chip engineering centres receive more than $10 million in new funding 32
Mar 20, 2017: Canadian collaboration to accelerate development of cancer treatments 33
Jul 21, 2016: New Method for Identifying Proteins Should have a Major Impact on the Development of New Biologics 35
Jun 20, 2016: Breast Cancer Cells Use Newfound Pathway to Survive Low Oxygen Levels in Tumors 36
Jun 07, 2016: Six new drug discovery acceleration projects supported by CQDM and Ontario Centres of Excellence 38
Mar 17, 2016: Stem cell therapy reverses age-related osteoporosis in mice 40
Feb 18, 2016: Engineering nanoparticles that can change their shape to deliver cancer drugs to tumours 41
Jan 07, 2016: Ontario Institute for Cancer Research invests $1.2 million to support oncology drug development in Ontario 42
Other Significant Developments 43
Sep 19, 2017: Google Glass app helps autistic children with social interactions 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
University of Toronto, Pharmaceuticals & Healthcare, Key Facts 2
University of Toronto, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University of Toronto, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University of Toronto, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University of Toronto, Deals By Therapy Area, 2011 to YTD 2017 9
University of Toronto, Medical Devices Deals, 2011 to YTD 2017 10
University of Toronto, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Celgene Partners with Recombinant Antibody Network 13
Edge Therapeutics Enters into Research and Discovery Agreement with St. Michael’s Hospital 15
Blueline Bioscience Forms Joint Venture with University of Toronto and University Health Network 16
Life Technologies Enters Into Joint Venture Agreement With Structural Genomics Consortium 17
Sanofi-aventis Enters Into Research Agreement With Sunnybrook Health Sciences Center 18
Advanced Proteome Therapeutics Enters into Option Agreement with Toronto Recombinant Antibody Centre 19
InDanio Biosciences Receives Intellectual Property Rights from University of Toronto 20
Kolltan Pharma Enters Into Licensing Agreement With University of Toronto For Anti-KIT Antibodies And Related IP 21
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University Of Toronto 22
NovaDigm Therapeutics Acquires Rights to Beta-Mannan Trisaccharide Conjugate from University of Alberta, Louisiana State University School of Medicine and University of Toronto 23
Regen BioPharma to Acquire Cancer Stem Cell Intellectual Property from University of Toronto 24
University of Toronto, Key Competitors 25
University of Toronto, Key Employees 26
University of Toronto, Other Locations 27
University of Toronto, Subsidiaries 27
University of Toronto, Affiliate 27
University of Toronto, Joint Venture 28

★海外企業調査レポート[University of Toronto-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MaaT Pharma-製薬・医療分野:企業M&A・提携分析
    Summary MaaT Pharma (MaaT) is a biotechchnology company that develop novel treatments for Gut Microbiota - dysbiosis related diseases. The company is working on two projects, which are in the developmental stage, namely, MaaT001, an innovative live frozen inoculum suspension and MaaT002, an innovati …
  • Sembcorp Industries Ltd:企業の戦略・SWOT・財務情報
    Sembcorp Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Sembcorp Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Accrol Group Holdings PLC (ACRL):企業の財務・戦略的SWOT分析
    Accrol Group Holdings PLC (ACRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • HomeServe plc (HSV):企業の財務・戦略的SWOT分析
    HomeServe plc (HSV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • RCL Foods Ltd (RCL):企業の財務・戦略的SWOT分析
    RCL Foods Ltd (RCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Central Garden & Pet Co (CENT):企業の財務・戦略的SWOT分析
    Central Garden & Pet Co (CENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Expro Holdings UK 2 Limited:企業の戦略的SWOT分析
    Expro Holdings UK 2 Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Benvenue Medical, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary Benvenue Medical, Inc (Benvenue Medical) is a manufacturer, designer and distributor of minimally invasive systems and other medical devices. The product portfolio of the company includes Luna, a 3D interbody fusion system designed for the treatment to restore disc height. Blazer, is a verte …
  • Metropolis Healthcare Ltd-医療機器分野:企業M&A・提携分析
    Summary Metropolis Healthcare Ltd (Metropolis Healthcare) is a healthcare service provider that provides pathology testing services. The center provides tests and test combinations, which ranges from routine screening tests to specialized molecular and genetic assays. It also specializes in clinical …
  • 3W Power S.A. (3W9K):電力:M&Aディール及び事業提携情報
    Summary 3W Power S.A. (3W Power) is a provider of energy equipment and services. It offers power supply systems and solutions. The company provides the most comprehensive product and service portfolios in uninterruptible power supply and power management fields. 3W Power offers a range of services s …
  • Shibuya Kogyo Co., Ltd.:企業の戦略・SWOT・財務情報
    Shibuya Kogyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shibuya Kogyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Cell Signaling Technology Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cell Signaling Technology Inc (CST) is a biological research and diagnostic products provider. The company offers primary antibodies, antibody samplers, secondary antibodies, antibody conjugates, elisa kits, chip kits and reagents proteomic analysis products, cellular assay kits, WB and IP r …
  • Evox Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Evox Therapeutics Ltd (Evox Therapeutics) is a biotechnology company focused on harnessing and engineering the natural delivery capabilities of exosomes, to develop novel medicines for various diseases. Its development pipeline is focused in the therapeutic areas of inflammatory, immune dise …
  • Kennametal Inc.:企業の戦略・SWOT・財務情報
    Kennametal Inc. - Strategy, SWOT and Corporate Finance Report Summary Kennametal Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Cloud Cap Technology Inc.:企業の戦略・SWOT・財務情報
    Cloud Cap Technology Inc. - Strategy, SWOT and Corporate Finance Report Summary Cloud Cap Technology Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • William Demant Holding AS (WDH):医療機器:M&Aディール及び事業提携情報
    Summary William Demant Holding AS (WDH) is a provider of hearing healthcare solutions that develops, manufactures and distributes products designed to aid people with hearing loss. The company offers hearing devices and implants, diagnostic instruments and personal communication devices. Its product …
  • Waste Management Inc (WM):企業の財務・戦略的SWOT分析
    Waste Management Inc (WM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • GP Strategies Corp (GPX):企業の財務・戦略的SWOT分析
    Summary GP Strategies Corp (GP Strategies) is a performance improvement company that offers sales and technical training, eLearning solutions, management consulting, and engineering services. The company offers solutions such as human capital management, managed learning services, off the shelf offe …
  • Novanta Inc (NOVT):企業の財務・戦略的SWOT分析
    Novanta Inc (NOVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • American Water Works Co Inc (AWK):企業の財務・戦略的SWOT分析
    Summary American Water Works Co Inc (AWW) is a utility company that offers fire protection and sanitation services. The company's services include water and wastewater services, military services, municipal and industrial contract, residual and home owner services. Its home owner services include wa …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆